A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats

Hypertension

Volumn 25, Issue 2, 1995, Pages 166-169

  Johnson, Robert A ^a   Lavesa, Manuel ^a   Askari, Bardia ^a   Abraham, Nader G ^b   Nasjletti, Alberto ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

autonomic nervous system; blood pressure; carbon monoxide; heme oxygenase

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; CHLORISONDAMINE; DEUTEROPORPHYRIN DERIVATIVE; DEUTEROPORPHYRIN IX 2,4 BISGLYCOL ZINC; HEME OXYGENASE; OXYGENASE INHIBITOR; PRAZOSIN; PROTOPORPHYRIN ZINC; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HEART OUTPUT; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0028814999     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.25.2.166     Document Type: Article

References (16)

1. Abraham NG, Lin JH-C, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem. 1988;20:543-558.
2. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557-2568.
3. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci. 1991;12:185-188.
4. Moore MR, McColl KEL, Rimington C, Goldberg A. Porphyrins and enzymes of the heme biosynthetic pathway. In: Wintrobe MM, ed. Disorders of Porphyrin Metabolism. New York, NY: Plenum Medical Book Co; 1987:21-44.
5. Schmidt HHHW. NO, CO and HO endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 1992;307:102-107.
6. Graser T, Vedernikov YP, Li DS. Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed Biochim Acta 1990;49:293-296.
7. Glaum SR, Miller RJ. Zinc protoporphyrin-IX blocks the effects of metabotropic glutamate receptor activation in the rat nucleus tractus solitarii. Mol Pharmacol. 1993;43:965-969.
8. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993;259:381-384.
9. Mitrione SM, Villalon P, Lutton JD, Levere RD, Abraham NG. Inhibition of human adult and fetal heme oxygenase by new synthetic heme analogues. Am J Med Sci. 1988;296:180-186.
10. Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology. 1989;10:365-369.
11. Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res. 1993;33:195-200.
12. Vreman HJ, Lee OK, Stevenson DK. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG. Am J Med Sci 1991;302:335-341.
13. G-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J Pharmacol Exp Ther 1992;261:240-245.
14. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 1990;186:301-311.
15. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989;243:388-390.
16. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 1990;86:213-219.